ViraPower™ Zeo Lentiviral Support Kit
Product Image
Invitrogen™

ViraPower™ Zeo Lentiviral Support Kit

The ViraPower™ Zeo Lentiviral Support Kit contains the necessary components to transfect 293FT cells to generate viral particles containing the詳細を見る
製品番号(カタログ番号)数量
K498500
または、製品番号K4985-00
20 reactions
製品番号(カタログ番号) K498500
または、製品番号K4985-00
価格(JPY)
293,500
Each
お問い合わせください ›
数量:
20 reactions
The ViraPower™ Zeo Lentiviral Support Kit contains the necessary components to transfect 293FT cells to generate viral particles containing the target gene. The kit contains the ViraPower™ Lentiviral Packaging Mix, Lipofectamine™ 2000 Reagent and Zeocin™ and is designed to be used with a ViraPower™ Lentiviral expression vector that has the Zeocin™ marker for stable selection. The kit is compatible with all of our ViraPower™ Lentiviral vectors, including the ViraPower™ HiPerform™ Lentiviral vectors.

Kit includes
• ViraPower™ Lentiviral Packaging Mix
• Lipofectamine™ 2000 (Cat # 11668027)
• Zeocin™ solution

For research use only. Not intended for any therapeutic or diagnostic use.
研究用途にのみご使用ください。診断目的には使用できません。
仕様
構成または誘導システム構造的
供給タイプLentiviral
使用対象(アプリケーション)ウイルス発現
製品タイプLentiviral Support Kit
数量20 reactions
選択剤(真核生物)ブラストサイジン
ベクターpLP
クローニング法Gateway
製品ラインViraPower
プロモーターRSV, CMV
タンパク質タグV5 Epitope Tag
Unit SizeEach
組成および保存条件
Contents
The ViraPower™ Zeo Lentiviral Support Kit includes the following components:
• 195 μg of ViraPower™ Packaging Mix (Contains 195 μL of a mixture of pLP1, pLP2, and pLP⁄VSVG plasmids, at 1 μg⁄μL in TE Buffer, pH 8.0)
• 0.75 ml of Lipofectamine™ 2000 (Cat # 11668027)
• 125 mg of Zeocin™ (1.25 ml of a 100mg⁄ml solution)

Storage
• ViraPower™ Packaging Mix: -20°C
• Lipofectamine™ 2000: 4°C (do not freeze)
• Zeocin™: -20°C, protected from light

よくあるご質問(FAQ)

I used one of your lentiviral vectors but am observing cytotoxic effects after transduction. Can you please help?

Possible causes include:

- large volume of viral supernatant used for transduction
- cells sensitive to Polybrene regaent
- too much antibiotic used for selection
- antibiotic used too soon after tranduction
- gene of interest is toxic to cells

I transduced my lentiviral stock into my mammalian cell line but am getting poor expression of my gene of interest. What could have happened?

Poor expression could result from low transduction efficiency, too low of a MOI, too much antibiotic used for selection, usage of antibiotic too soon after transduction, harveting cells too soon after transduction, having a gene of interest that is toxic to cells, or rerrangement in the LTR regions of the expression construct plasmid DNA.

I transduced my lentiviral stock into my mammalian cell line but am getting no expression of my gene of interest. What could have gone wrong?

Here are some possible causes and solutions:
- Promoter silencing; CMV promoter is prone to silencing especially in mouse and rat cells, screen multiple antibiotic resistant clones and select the one with the highest expression levels
- Viral stocks stored incorrectly; aliquot and store at -80 degrees C, do not freeze/thaw more than 3 times

I prepared a lentiviral stock using one of your lentiviral vectors. I am trying to determine the titer using antibiotic selection but am not able to since the cells are very confluent and I am not getting antibiotic-resistant clones. Can you please offer some tips?

Here are some possible causes and solutions:

- Too little antibotic used for selection
- Selection performed on confluent cells; replate cells
- Viral supernatant not diluted sufficiently; titer lentivus using a wider range of 10-fold serial dilutions

I am using one of your lentiviral vectors and am getting a low lentiviral titer. Can you offer some troubleshooting tips?

Possible causes include:

- low transfection efficiency; Use a high-quality plasmid prep, 293FT cells under passage 16, ensure removal of Geneticin during transfection, ensure correct DNA:lipid ratio, and that cells are plated at the correct confluency
- transfected cells are not cultured in medium containing sodium pyruvate; this reagent provides an extra energy source for cells
- viral supernatant harvested too early; viral supernatants can generally be collected 48-72 hrs post-transfection
- viral supernatant too dilute; concentrate virus using CsCl purification
- viral supernatant frozen and thawed multiple times; 3 times should be the maximum freeze/thaw
- gene of interest is large; viral titers decrease as size of insert increases, inserts larger than 5.6 kb are not recommended
- rearrangement in the LTR region of the epxression construct plasmid DNA; use Stb3 cells for transformatin of the lentiviral construct
- poor choice of titering cell line; use HT1080 cells or similar cell line
- Polybrene reagent is not included during transduction; transduce lentiviral construct into cells in the presence of Polybrene reagent
- Lipofectamine reagent handled incorrectly; ensure proper storage and mix gently before use
- Use fluorescence micrscopy to check titer with HiPerform FastTiter lentivirus

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.